Glimepiride Tablets
Glimepiride 1 Tabletis a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, glimepiride 2 tablet(Dibei), as the first hypoglycemic product of Beilu Pharma, was first listed in China and belongs to the second class of national new drugs.
Productname:GlimepirideTabletsSpecifications:glimepiride1mg×30tablets;glimepiride2mg×15tablets;glimepiride2mg×30tabletsCharacteristics:WhitetabletIndications:AsoneoftheoralantidiabeticdrugsproducedbyBeiluPharma,ourglimepiridetabletsareonlysuitablefortype2diabetesthatcannotfullycontrolbloodsugarthroughdietcontrol,exercisetherapyandweightloss.Glimepiridetabletsarenotsuitablefortype1diabetes(forexample,thetreatmentofdiabeticpatientswithahistoryofketoacidosis),diabeticketoacidosisorTreatmentofpre-diabeticcomaorcoma.UsageandDosage:PleaserefertothepackageinsertAdversereactions,Contraindications,Precautions:Pleaserefertothepackageinsert.Storage:Shade,seal,andkeepinadryplace.Packaging:Aluminumplasticpackaging,15pillsate,1plate/box;15pillsate,2plates/box.Shelflife:24monthsAdvantagesofGlimepirideTabletsDoubleeffectdirectlyhitthehypoglycemiccoreDoubleeffect:Glimepiridetabletscanpromoteinsulinsecretionandimproveinsulinresistance.Atthesametime,itcanimprovethetwomajorpathophysiologicalabnormalitiesofinsulinsecretionandinsulinresistanceinpatientswithtype2diabetes.Efficientlyreducepostprandialbloodglucose,fastingbloodglucoseandglycosylatedhaemoglobinGlimepiride 2 mg oral tabletmonotherapycancomprehensivelyreduceFPGPPGandHbA1cinnewlydiagnosedT2DMpatientsCombinationtherapy,suchascombinedmetformin,acarbose,etc.,hasamoresignificantoverallhypoglycemiceffectLesshypoglycemia,lessweightimpact,highsafetyShort-termtreatment,theriskofglimepiridehypoglycemiaisonly1/3ofthatofGlibenclamideLong-termtreatment,theriskofglimepiridehypoglycemiaisonly1/7ofthatofGlibenclamideGlimepiridehasasmallimpactontheweightofT2DMpatientsOnceadaytoimprovepatientcomplianceIfthepatient'scomplianceispoor,Glimepiridetabletsshouldbeselected,onceaday.
Beijing pharmaceuticalsisa professional contrast media manufacturer, we provideglimepiride 1mg tablets, glimepiride tab 1mg, glimepiride package insert, mri contrast mediumand etc. Want to know glimepiride 2mg tablets used foror side effects of glimepiride 1mg tablet? Please contact us.
在线联系供应商
Other supplier products
| Anti-Diabetic Drugs | The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th... | |
| Ferric Ammonium Citrate Effervescent Granules | Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the m... | |
| Iohexol Injection | What Is Iohexol? Iohexol Injection is one of the different types of contrast media. Compared with a traditional ionic Contrast Media, Iohexol Or... | |
| Contrast Media Manufacturing Company | For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body... | |
| Contrast Media Manufacturing Company | For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body... |
Same products
| Mold Components | 卖方: Packson Mold Co.,Ltd | We provide custom made plastic parts-Sliders, inserts, lifters, blocks, ejector pins, and other m... | |
| Custom Metal Machining Parts | 卖方: Packson Mold Co.,Ltd | Packson provides our customers a various CNC machining services to our customers, including milli... | |
| Clean Room Injection | 卖方: Packson Mold Co.,Ltd | Packson - Medial Injection Moulding Cleanroom Expert Packson specializes in delivering top-notch ... | |
| Medical Plastic Injection Molding | 卖方: Packson Mold Co.,Ltd | Packson - Medical Plastic Injection Molding Expert Packson sets itself apart from other medical i... | |
| CNC Metal Machining Parts | 卖方: Packson Mold Co.,Ltd | Packson is a contract manufacturer specializing in CNC Milling, CNC Turning, CNC Drilling service... |
















